SCROLL

SCROLL
The Institute of Metabolic Disorders (IMD) focuses on drug discovery for the treatment of lipid-dependent fatty liver disease (NAFLD/NASH). The Institute will strive to become a respected leader in the field of metabolic disease treatment. Our goal is to increase the quality of life for individuals with metabolic pathologies associated with loss of liver function.
Institute of Metabolic Disorders
1000 Waterview Drive
Hamilton, NJ 08690